EMAIL THIS PAGE TO A FRIEND

PloS one

A chemical genetics analysis of the roles of bypass polymerase DinB and DNA repair protein AlkB in processing N2-alkylguanine lesions in vivo.


PMID 24733044

Abstract

DinB, the E. coli translesion synthesis polymerase, has been shown to bypass several N2-alkylguanine adducts in vitro, including N2-furfurylguanine, the structural analog of the DNA adduct formed by the antibacterial agent nitrofurazone. Recently, it was demonstrated that the Fe(II)- and α-ketoglutarate-dependent dioxygenase AlkB, a DNA repair enzyme, can dealkylate in vitro a series of N2-alkyguanines, including N2-furfurylguanine. The present study explored, head to head, the in vivo relative contributions of these two DNA maintenance pathways (replicative bypass vs. repair) as they processed a series of structurally varied, biologically relevant N2-alkylguanine lesions: N2-furfurylguanine (FF), 2-tetrahydrofuran-2-yl-methylguanine (HF), 2-methylguanine, and 2-ethylguanine. Each lesion was chemically synthesized and incorporated site-specifically into an M13 bacteriophage genome, which was then replicated in E. coli cells deficient or proficient for DinB and AlkB (4 strains in total). Biochemical tools were employed to analyze the relative replication efficiencies of the phage (a measure of the bypass efficiency of each lesion) and the base composition at the lesion site after replication (a measure of the mutagenesis profile of each lesion). The main findings were: 1) Among the lesions studied, the bulky FF and HF lesions proved to be strong replication blocks when introduced site-specifically on a single-stranded vector in DinB deficient cells. This toxic effect disappeared in the strains expressing physiological levels of DinB. 2) AlkB is known to repair N2-alkylguanine lesions in vitro; however, the presence of AlkB showed no relief from the replication blocks induced by FF and HF in vivo. 3) The mutagenic properties of the entire series of N2-alkyguanines adducts were investigated in vivo for the first time. None of the adducts were mutagenic under the conditions evaluated, regardless of the DinB or AlkB cellular status. Taken together, the data indicated that the cellular pathway to combat bulky N2-alkylguanine DNA adducts was DinB-dependent lesion bypass.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

77664
3-Methyl-1-butanol, analytical standard
C5H12O
59092
3-Methylbutanol, analytical standard
C5H12O
C3161
Calcium phosphate tribasic, BioReagent, plant cell culture tested, powder
HCa5O13P3
C5267
Calcium phosphate tribasic, 34.0-40.0% Ca basis
HCa5O13P3
702153
Hydroxyapatite, nanoparticles, dispersion, 10 wt. % in H2O, <200 nm particle size (BET)
Ca5HO13P3
H0252
Hydroxyapatite, Type I, buffered aqueous suspension
HCa5O13P3
55497
Hydroxyapatite, ′fast flow′
HCa5O13P3
04238
Hydroxyapatite, puriss., meets analytical specification of Ph. Eur., BP, FCC, E341, ≥90% (calculated on glowed substance)
HCa5O13P3
574791
Hydroxyapatite, synthetic, 99.8% trace metals basis (excludes Mg)
HCa5O13P3
21223
Hydroxyapatite, purum p.a., ≥90% (as Ca3(PO4)2, KT)
HCa5O13P3
289396
Hydroxyapatite, reagent grade, powder, synthetic
HCa5O13P3
677418
Hydroxyapatite, nanopowder, <200 nm particle size (BET), ≥97%, synthetic
HCa5O13P3
693863
Hydroxyapatite, nanopowder, <200 nm particle size (BET), contains 5 wt. % silica as dopant, synthetic
HCa5O13P3
T9281
N,N,N′,N′-Tetramethylethylenediamine, BioReagent, suitable for electrophoresis, ~99%
C6H16N2
T7024
N,N,N′,N′-Tetramethylethylenediamine, BioReagent, for molecular biology, ≥99% (GC)
C6H16N2
411019
N,N,N′,N′-Tetramethylethylenediamine, ≥99.5%, purified by redistillation
C6H16N2
T22500
N,N,N′,N′-Tetramethylethylenediamine, ReagentPlus®, 99%
C6H16N2
127019
N-Methylethylenediamine, 95%
C3H10N2